Ok. So I did not pick Pfizer as the Big Pharma back in Feb....

Ok. So I did not pick Pfizer as the Big Pharma back in Feb. However, the important thing is that there are many further and substantial substantial opportunities for PSD in the pipeline. Here are some of the major ones that I wanted to remind people of back in Feb.

1) Psivida currently negotiating a licencing deal with a top 5 global pharmaceutical company by end of March 2007 (my bet is Roche or Novartis).
2) Multiple evaluation agreements signed with at least two other top 5 global pharma companies for Psivida's Biosilicon and drug delivery technolgy in the fields of opthamology and oncology.
3) Evaluation agreement with a large global medical device company to evaluate cardiovascular delivery of drugs usings Psivida's technology
4) A recently announced collaboration with a global electronics company to evaluate the Biosilicon technolgy for the development of transdermal drug delivery systems.
5) An agreement with ITOCHU Corporation (one of the world's largest comapnies) to develop technologies for the Japan and Asian market.
6) Pending spin out of Aion Diagnostics and trade sale or out licencing all non-core applications such as orthopedics and Biosilicon food industry products

Too many other far reaching opportunities and collaborations to mention. Best you review Psivida's ASX announcements if not familiar. Happy days in 2007 with value recognition imminent, with or without Peptech in my opinion.

Rgds
Sarge